Delcath Systems Inc
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development… Read more
Delcath Systems Inc (DCTH) - Total Assets
Latest total assets as of December 2025: $123.63 Million USD
Based on the latest financial reports, Delcath Systems Inc (DCTH) holds total assets worth $123.63 Million USD as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Delcath Systems Inc - Total Assets Trend (1999–2025)
This chart illustrates how Delcath Systems Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Delcath Systems Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
Delcath Systems Inc's total assets of $123.63 Million consist of 96.7% current assets and 3.3% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 35.2% |
| Accounts Receivable | $11.74 Million | 9.5% |
| Inventory | $10.25 Million | 8.3% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (1999–2025)
This chart illustrates how Delcath Systems Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Delcath Systems Inc's current assets represent 96.7% of total assets in 2025, an increase from 95.0% in 1999.
- Cash Position: Cash and equivalents constituted 35.2% of total assets in 2025, down from 93.3% in 1999.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 1999.
- Asset Diversification: The largest asset category is accounts receivable at 9.5% of total assets.
Delcath Systems Inc Competitors by Total Assets
Key competitors of Delcath Systems Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Delcath Systems Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Delcath Systems Inc generates 0.69x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Delcath Systems Inc generates $ 2.18 in net profit.
Delcath Systems Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 10.92 | 12.01 | 2.99 |
| Quick Ratio | 9.98 | 10.88 | 2.88 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $108.58 Million | $ 67.62 Million | $ 20.11 Million |
Delcath Systems Inc - Advanced Valuation Insights
This section examines the relationship between Delcath Systems Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.02 |
| Latest Market Cap to Assets Ratio | 2.40 |
| Asset Growth Rate (YoY) | 61.4% |
| Total Assets | $123.63 Million |
| Market Capitalization | $296.30 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Delcath Systems Inc's assets at a significant premium ( 2.40x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: Delcath Systems Inc's assets grew by 61.4% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Delcath Systems Inc (1999–2025)
The table below shows the annual total assets of Delcath Systems Inc from 1999 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $123.63 Million | +61.42% |
| 2024-12-31 | $76.59 Million | +98.35% |
| 2023-12-31 | $38.61 Million | +116.17% |
| 2022-12-31 | $17.86 Million | -46.08% |
| 2021-12-31 | $33.12 Million | -4.36% |
| 2020-12-31 | $34.63 Million | +143.70% |
| 2019-12-31 | $14.21 Million | +107.66% |
| 2018-12-31 | $6.84 Million | -22.99% |
| 2017-12-31 | $8.89 Million | -74.78% |
| 2016-12-31 | $35.24 Million | +123.98% |
| 2015-12-31 | $15.73 Million | -33.79% |
| 2014-12-31 | $23.76 Million | -35.94% |
| 2013-12-31 | $37.10 Million | +21.73% |
| 2012-12-31 | $30.47 Million | -13.53% |
| 2011-12-31 | $35.24 Million | -30.32% |
| 2010-12-31 | $50.58 Million | +37.41% |
| 2009-12-31 | $36.81 Million | +224.04% |
| 2008-12-31 | $11.36 Million | -37.27% |
| 2007-12-31 | $18.11 Million | +106.60% |
| 2006-12-31 | $8.76 Million | -32.21% |
| 2005-12-31 | $12.93 Million | +75.85% |
| 2004-12-31 | $7.35 Million | +202.48% |
| 2003-12-31 | $2.43 Million | +34.14% |
| 2002-12-31 | $1.81 Million | -46.76% |
| 2001-12-31 | $3.40 Million | -42.65% |
| 2000-12-31 | $5.93 Million | +889.06% |
| 1999-12-31 | $600.00K | -- |